Concepedia

Author

Petra Rietschel

Regeneron (United States)

Also Known As

P Rietschel, P. Rietschel, Petra Rietschel

85

Publications

3.4K

Citations

16

H-Index

26

Concepts

All Affiliations

Regeneron (United States)Istanbul Medeniyet UniversityDnipro State Medical UniversityIstanbul University-CerrahpaşaTrakya University
PR

About

Petra Rietschel is an author at Regeneron (United States) specializing in medicine, lung cancer, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

1.6K

2

Health Sciences

4

4

1.5K

3

Cell Biology

1

1

22

4

Diabetes

1

1

678

5

Epidemiology

1

1

678

Petra Rietschel

×

22

Publications

3.3K

Citations

16

H-Index

YearCitations

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Ahmet Sezer, Mahmut Gümüş, Igor Bondarenko,

The Lancet

2021

772

Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy

Colleen Hadigan, James B. Meigs, Colleen Corcoran,

Clinical Infectious Diseases

2001

678

Variates of Survival in Metastatic Uveal Melanoma

Petra Rietschel, Katherine S. Panageas, Christine Hanlon,

Journal of Clinical Oncology

2005

310

Assessment of Growth Hormone Dynamics in Human Immunodeficiency Virus-Related Lipodystrophy1

Petra Rietschel, Colleen Hadigan, Colleen Corcoran,

The Journal of Clinical Endocrinology & Metabolism

2001

292

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze,

Nature Medicine

2022

268

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

Gary K. Schwartz, William D. Tap, Li-Xuan Qin,

The Lancet Oncology

2013

186

Prevalence of Hypogonadism among Men with Weight Loss Related to Human Immunodeficiency Virus Infection Who Were Receiving Highly Active Antiretroviral Therapy

Petra Rietschel, Colleen Corcoran, Takara L. Stanley,

Clinical Infectious Diseases

2000

171

Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy

Jeannie S. Huang, Petra Rietschel, Colleen Hadigan,

AIDS

2001

118

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial

Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze,

Journal of Thoracic Oncology

2023

85

First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial

Mustafa Özgüroğlu, Ahmet Sezer, Mahmut Gümüş,

The Lancet Oncology

2023

82

Page 1